Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
25.5%
% of CANC's 47 holdings also in FBT
40.0%
% of FBT's 31 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 4.6% | 3.8% | 3.8% |
 |
GILEAD SCIENCES INC | 5.3% | 3.6% | 3.6% |
|
EXELIXIS INC | 3.6% | 4.5% | 3.6% |
|
INCYTE CORP | 4.3% | 3.5% | 3.5% |
|
ILLUMINA INC | 4.2% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to FBT
 |
ASTRAZENECA PLC | 5.6% |
|
BLUEPRINT MEDICINES CORP. | 4.6% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
DAIICHI SANKYO CO LTD | 3.0% |
|
GUARDANT HEALTH, INC. | 2.6% |
|
REGENERON PHARMACEUTICALS | 2.5% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.4% |
|
MERCK & CO. INC. | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.3% |
CANC Underweight Relative to FBT
|
NATERA INC | -4.3% |
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
REPLIGEN CORP | -3.8% |
|
NEUROCRINE BIOSCIENCES INC | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
WATERS CORP | -3.6% |
 |
ALKERMES PLC | -3.6% |
|
UNITED THERAPEUTICS CORP | -3.4% |